Temporal trends of time in therapeutic range and incidence of cardiovascular events in patients with non-valvular atrial fibrillation-Reference-Cited by-同舟云学术

Temporal trends of time in therapeutic range and incidence of cardiovascular events in patients with non-valvular atrial fibrillation

Published:2018-08 Issue: Volume:54 Page:34-39
ISSN:0953-6205
Container-title:European Journal of Internal Medicine
language:en
Short-container-title:European Journal of Internal Medicine

Author:

Pastori Daniele^ORCID,Farcomeni Alessio,Saliola Mirella,Del Sole Francesco,Pignatelli Pasquale,Violi Francesco,Lip Gregory Y.H.,Casciaro Marco Antonio,Ferro Domenico,Menichelli Danilo,Carnevale Roberto,Albanese Fabiana,Di Stefano Tiziana,Iannucci Patrizia,Sabbatini Elio,Iannilli Claudia

Publisher

Elsevier BV

Subject

Internal Medicine

Reference32 articles.

1. Atrial fibrillation and myocardial infarction: a systematic review and appraisal of pathophysiologic mechanisms;Violi;J Am Heart Assoc,2016

2. Safety and efficacy of well managed warfarin. A report from the Swedish quality register Auricula;Sjogren;Thromb Haemost,2015

3. Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range;Connolly;Circulation,2008

4. Anticoagulation control and prediction of adverse events in patients with atrial fibrillation: a systematic review;Wan;Circ Cardiovasc Qual Outcomes,2008

5. Association of Preceding Antithrombotic Treatment with Acute Ischemic Stroke Severity and in-Hospital Outcomes among Patients with Atrial Fibrillation;Xian;JAMA,2017

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of the quality of anticoagulation on the risk of stroke, thrombotic events, hemorrhagic events, and death in patients with nonvalvular atrial fibrillation on acenocoumarol in Real-World Data;F1000Research;2024-09-13

2. Drug management of atrial fibrillation in light of guidelines and current evidence: an Italian Survey on behalf of Italian Association of Arrhythmology and Cardiac Pacing;Journal of Cardiovascular Medicine;2023-05-24

3. Association of proprotein convertase subtilisin/kexin type 9 (PCSK9) levels with abnormally high ankle-brachial index in atrial fibrillation;Kardiologia Polska;2023-04-28

4. Anticoagulation Management in Patients Receiving Warfarin at Private Cardiac Centers in Addis Ababa, Ethiopia;Journal of Blood Medicine;2023-02

5. Anticoagulation control, outcomes, and associated factors in long-term-care patients receiving warfarin in Africa: a systematic review;Thrombosis Journal;2022-10-03